Loading…
Estimation of purity of antimicrobial lead compound sulfonamide‐anthranilate derivative methyl‐ester‐toluene‐sulfonamide using LC to develop a new drug application
The newly synthesized lead molecule methyl‐ester‐toluene‐sulfonamide is the combined derivative of sulfonamide‐anthranilate. It was estimated by gradient elution using 0.1% triethylamine in water with pH 2.0 as mobile phase A and the mixture of acetonitrile and tetrahydrofuran in the ratio of 975:25...
Saved in:
Published in: | Biomedical chromatography 2023-08, Vol.37 (8), p.e5646-n/a |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The newly synthesized lead molecule methyl‐ester‐toluene‐sulfonamide is the combined derivative of sulfonamide‐anthranilate. It was estimated by gradient elution using 0.1% triethylamine in water with pH 2.0 as mobile phase A and the mixture of acetonitrile and tetrahydrofuran in the ratio of 975:25 (v/v) as mobile phase B at a flow rate of 0.8 ml/min and 210 nm wavelength on an Agilent 1260 infinity series HPLC system equipped with a diode array detector. The column used was ACE 3 C18‐PFP (250 × 4.6 mm, 3 μm i.d.) operating at 40°C. The gradient program was time (min)/% B: 0.0/50, 3.0/50, 15.0/70, 25.0/90, 30.0/90, 31/50, and 38/50. The method is simple, accurate, rapid, and selective. The method was linear with a concentration range of 1.6–240 μg/ml. The accuracy data obtained were 98.5–100.5%. The method validation data and quality by design–based robustness study results indicate that the developed method is robust and fit for routine use in the quality control laboratory. Therefore, the ready availability of the method can be useful in pharmaceutical new drug development. |
---|---|
ISSN: | 0269-3879 1099-0801 |
DOI: | 10.1002/bmc.5646 |